Cargando…

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies

Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sriboonvorakul, Natthida, Pan-Ngum, Wirichada, Poovorawan, Kittiyod, Muangnoicharoen, Sant, Quinn, Lauren M., Tan, Bee K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621185/
https://www.ncbi.nlm.nih.gov/pubmed/34830706
http://dx.doi.org/10.3390/jcm10225424
_version_ 1784605396541898752
author Sriboonvorakul, Natthida
Pan-Ngum, Wirichada
Poovorawan, Kittiyod
Muangnoicharoen, Sant
Quinn, Lauren M.
Tan, Bee K.
author_facet Sriboonvorakul, Natthida
Pan-Ngum, Wirichada
Poovorawan, Kittiyod
Muangnoicharoen, Sant
Quinn, Lauren M.
Tan, Bee K.
author_sort Sriboonvorakul, Natthida
collection PubMed
description Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai cohort comprising of individuals with T2DM (n = 65 single-drug-treated; n = 38 multi-drug-treated) compared to healthy controls (n = 104) using liquid chromatography-mass spectrometry. Age and BMI were significantly lower in the healthy controls compared to the single or multi-treated T2DM groups. The BCAA (leucine and valine) were significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p < 0.001) and isoleucine was significantly lower in the single-treated compared to the healthy controls (p = 0.014). These findings beg the question whether BCAAs supplementation be beneficial in T2DM patients treated with single or multi-drug therapy? Tyrosine was significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p = 0.002), whereas phenylalanine was significantly higher in the multi-treated T2DM group compared to the single treated T2DM group (p = 0.045). We provide novel insights into the effects of diabetes treatments on these amino acids in insulin resistant states such as T2DM in a unique but understudied Thai population.
format Online
Article
Text
id pubmed-8621185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86211852021-11-27 Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies Sriboonvorakul, Natthida Pan-Ngum, Wirichada Poovorawan, Kittiyod Muangnoicharoen, Sant Quinn, Lauren M. Tan, Bee K. J Clin Med Article Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai cohort comprising of individuals with T2DM (n = 65 single-drug-treated; n = 38 multi-drug-treated) compared to healthy controls (n = 104) using liquid chromatography-mass spectrometry. Age and BMI were significantly lower in the healthy controls compared to the single or multi-treated T2DM groups. The BCAA (leucine and valine) were significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p < 0.001) and isoleucine was significantly lower in the single-treated compared to the healthy controls (p = 0.014). These findings beg the question whether BCAAs supplementation be beneficial in T2DM patients treated with single or multi-drug therapy? Tyrosine was significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p = 0.002), whereas phenylalanine was significantly higher in the multi-treated T2DM group compared to the single treated T2DM group (p = 0.045). We provide novel insights into the effects of diabetes treatments on these amino acids in insulin resistant states such as T2DM in a unique but understudied Thai population. MDPI 2021-11-20 /pmc/articles/PMC8621185/ /pubmed/34830706 http://dx.doi.org/10.3390/jcm10225424 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sriboonvorakul, Natthida
Pan-Ngum, Wirichada
Poovorawan, Kittiyod
Muangnoicharoen, Sant
Quinn, Lauren M.
Tan, Bee K.
Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title_full Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title_fullStr Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title_full_unstemmed Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title_short Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
title_sort low branched chain amino acids and tyrosine in thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621185/
https://www.ncbi.nlm.nih.gov/pubmed/34830706
http://dx.doi.org/10.3390/jcm10225424
work_keys_str_mv AT sriboonvorakulnatthida lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies
AT panngumwirichada lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies
AT poovorawankittiyod lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies
AT muangnoicharoensant lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies
AT quinnlaurenm lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies
AT tanbeek lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies